ATOS Atossa Genetics Inc

Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.

$4.19  +0.08 (1.95%)
As of 07/23/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/08/2012
Outstanding shares:  120,824,368
Average volume:  25,600,968
Market cap:   $496,588,152
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    04962H506
ISIN:        US04962H5063
Sedol:      BFXZQW0
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.66
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy